帕金森病中胆红素相关纹状体[18F]FP-CIT摄取差异
结果显示IPD组胆红素水平显著高于对照组,且胆红素与SNBR相关性最强;在IPD组更受累的后壳核中胆红素与SNBR正相关,而ET组为负相关;尿酸无此差异或关系。
要点
- 早期未用药IPD患者血清胆红素水平显著高于ET对照组。
- 胆红素而非尿酸是与纹状体多巴胺转运体摄取相关的最显著抗氧化标志物。
- IPD组后壳核胆红素与SNBR正相关,ET组则为负相关。
核心结论
- 胆红素而非尿酸是早期未用药IPD患者[18F]FP-CIT PET/CT所评估多巴胺能缺陷的最显著抗氧化标志物。
主要发现
- IPD组胆红素水平显著高于对照组(P=0.026)。
- 在IPD组中胆红素是与SNBR相关性最强的因素(P<0.001),尿酸无此差异或关系。
- IPD组更受累后壳核胆红素与SNBR呈正相关(Pearson相关系数ρ=0.456;P<0.001),ET组呈负相关(ρ=-0.440,P<0.001)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE OF THE REPORT: Oxidative stress is a leading factor in the pathogenesis of idiopathic Parkinson disease (IPD). Two intrinsic antioxidative molecules, bilirubin and uric acid, are known to protect dopaminergic neurons from oxidative stress in IPD. The objective of this study was to determine the relationship between basal serum levels of 2 molecules and dopaminergic deficit assessed by dopamine transporter imaging with F-fluorinated-N-3-fluoropropyl-2-β-carboxymethoxy-3-β-(4-iodophenyl)nortropane ([F]FP-CIT) PET/CT in patients with early-stage drug-naive IPD. METHODS: Cases of IPD patients who possess the levels of uric acid and bilirubin within a month from [F]FP-CIT PET/CT from January 2011 to December 2016 were retrospectively reviewed. As a control, the same criteria applied to patients with essential tremor (ET). PET images were analyzed using volume-of-interest templates for 12 striatal subregions and 1 occipital area, and the specific-to-nonspecific binding ratio (SNBR) was calculated. RESULTS: One hundred five patients with drug-naive, early-stage IPD and 62 patients with ET were finally included. Levels of bilirubin were significantly higher in the IPD group than in controls (P = 0.026), and bilirubin level was the factor showing the most correlations with SNBR in IPD (P < 0.001), whereas uric acid showed no such difference or relationship. Furthermore, levels of bilirubin showed a positive correlation with SNBR in more affected posterior putamen in the IPD group (Pearson correlation coefficient, ρ = 0.456; P < 0.001), but a negative one in the ET group (ρ = -0.440, P < 0.001). CONCLUSIONS: Bilirubin, not uric acid, was the most significant antioxidant marker for dopaminergic deficit in early-stage drug-naive IPD assessed by [F]FP-CIT PET/CT.
引用
- Lee DY, Oh M, Kim SJ, et al. Bilirubin-Related Differential Striatal [18F]FP-CIT Uptake in Parkinson Disease. Clin Nucl Med. 2019. PMID: 31490312. doi:10.1097/RLU.0000000000002749
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。